Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Parham, C S

    1. BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.
      G J Grover, C S Parham, D B Whigan and J G Mitroka
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 380-387;

  2. Parini, A

    1. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
      I Limon-Boulez, F Tesson, C Gargalidis-Moudanos and A Parini
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 359-364;

  3. Parker, E S

    1. Low level hyperbaric antagonism of diazepam's locomotor depressant and anticonvulsant properties in mice.
      D L Davies, M Bejanian, E S Parker, J Mørland, M B Bolger, R D Brinton and R L Alkana
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 667-675;

  4. Parsons, M E

    1. Characterization of the antinociceptive properties of cimetidine and a structural analog.
      B Y Li, J W Nalwalk, L A Barker, P Cumming, M E Parsons and L B Hough
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 500-508;

  5. Pasyk, E A

    1. A G protein, not cyclic AMP, mediates effects of VIP on the inwardly rectifying K+ channels in endothelial cells.
      E A Pasyk, S Cipris and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 690-696;

  6. Peterson, P D

    1. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
      J Haynes, D W Killilea, P D Peterson and W J Thompson
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 752-757;

  7. Pieretti, S

    1. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
      A Capasso, A Di Giannuario, A Loizzo, S Pieretti, S Sagratella and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 743-751;

  8. Pineyro, G

    1. Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration.
      G Piñeyro and P Blier
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 697-707;

  9. Powell, W S

    1. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.
      W S Powell, J Rokach, S P Khanapure, S Manna, M Hashefi, S Gravel, R J Macleod, J R Falck and R K Bhatt
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 728-736;

  10. Poyser, R H

    1. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
      A Bril, B Gout, M Bonhomme, L Landais, J F Faivre, P Linee, R H Poyser and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 637-646;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement